Cargando…
A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria
BACKGROUND: Gram-positive bacteria, especially methicillin-resistant Staphylococcus aureus (MRSA) and enterococci, have shown a remarkable ability to develop resistance to antimicrobial agents. OBJECTIVE: We aimed to assess possible enhancement of the antimicrobial activity of vancomycin, amoxicilli...
Autores principales: | Sallam, Mariam Madkour, Abou-Aisha, Khaled, El-Azizi, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153292/ https://www.ncbi.nlm.nih.gov/pubmed/27994476 http://dx.doi.org/10.2147/IDR.S120227 |
Ejemplares similares
-
1705. Filamentous Hemagglutinin Polyclonal Antibodies Protect against Multidrug resistant Gram-negative bacteria
por: Youssef, Eman, et al.
Publicado: (2022) -
Shapeshifting bullvalene-linked vancomycin dimers as effective antibiotics against multidrug-resistant gram-positive bacteria
por: Ottonello, Alessandra, et al.
Publicado: (2023) -
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria
por: Elliott, Alysha G., et al.
Publicado: (2020) -
An Update on Eight “New” Antibiotics against Multidrug-Resistant Gram-Negative Bacteria
por: Yusuf, Erlangga, et al.
Publicado: (2021) -
Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria
por: Silva, José Tiago, et al.
Publicado: (2021)